Is it unusual to get a coagulase-negative Staphylococcus urinary tract infection when a transvaginal tape is in situ?

No, it is NOT unusual to get a coagulase-negative Staphylococcus UTI with transvaginal tape (TVT) in situ

Coagulase-negative Staphylococci (CoNS), particularly S. epidermidis, are well-established pathogens in UTIs associated with indwelling devices and foreign materials in the urinary tract, making this a predictable complication of TVT placement.

Why This Occurs

CoNS are the most common cause of infections related to indwelling devices and foreign materials 1. The key mechanism involves:

• Biofilm formation: CoNS possess bacterial polysaccharide components that facilitate attachment and persistence on foreign materials 1
• Device-associated colonization: The TVT mesh acts as a foreign body substrate for bacterial adherence, similar to catheters and other urologic prosthetics

Clinical Context and Species Distribution

The specific CoNS species matters for understanding the clinical picture:

• S. epidermidis (45-70% of CoNS UTIs) is predominantly isolated from patients with indwelling catheters, complicated cases, and foreign materials 2, 3
• S. saprophyticus (17-34% of CoNS UTIs) occurs mainly in young, sexually active women with uncomplicated acute cystitis and is NOT typically device-associated 2, 3

With TVT in situ, you should expect S. epidermidis rather than S. saprophyticus 2, 3.

Distinguishing True Infection from Contamination

A common pitfall is dismissing CoNS as contaminants. Key features suggesting true infection:

• Colony counts: Standard UTI thresholds apply (≥10^5 CFU/mL for clean-catch, ≥10^3 CFU/mL for catheterized specimens)
• Clinical symptoms: Dysuria, frequency, urgency, suprapubic pain, or systemic signs
• Pure culture: Single organism rather than mixed flora
• Repeat cultures: Consistent isolation of the same species

Antimicrobial Considerations

CoNS isolated from device-associated UTIs show concerning resistance patterns:

• High resistance rates: 42% multiply resistant in nosocomial settings versus only 4.2% for S. saprophyticus 3
• Methicillin resistance: 60-67% of S. epidermidis and S. haemolyticus are oxacillin-resistant 2
• Reliable coverage: All isolates remain sensitive to vancomycin and linezolid 4

Empiric therapy should cover methicillin-resistant CoNS if the patient is systemically ill or has risk factors for resistant organisms 5.

Management Algorithm

1. Confirm true infection (not contamination) using clinical and microbiological criteria above
2. Obtain culture and susceptibilities before starting antibiotics when possible
3. Consider mesh involvement: If recurrent CoNS UTI occurs, evaluate for mesh erosion or exposure into the urinary tract
4. Treatment duration: 7-14 days for most CA-UTI cases 5, though shorter courses may suffice for mild infections after foreign body removal
5. Device removal consideration: If infection persists despite appropriate antibiotics, mesh removal may be necessary (similar principles to other device-related infections 1)

Bottom Line

CoNS UTI with TVT in situ represents a device-associated infection, not an unusual occurrence. The mesh provides a nidus for biofilm formation, particularly by S. epidermidis. Treat as a complicated UTI with attention to antimicrobial resistance patterns and consider mesh involvement if infection recurs or fails to respond to appropriate therapy.